Sonendo
Wei Huang has over 20 years of experience in various roles related to program management, product development, operations, and manufacturing engineering. Wei has held positions at companies such as Edwards Lifesciences, Sonendo® Inc., Applied Biosystems, and Hyseq Inc. Notably, they served as a Director of Program Management at Edwards Lifesciences and as a Director of Product Development at Sonendo® Inc. During their time at Edwards Lifesciences, they managed all operations functions for new product introduction and transfer, including launching 3 generations of GlucoClear products. At Applied Biosystems, they were responsible for manufacturing process development of Micro-Array and the reagent business.
Wei Huang pursued a Bachelor's degree in Aerospace at Northwestern Polytechnical University from 1990 to 1994. Later, they obtained a Master's degree in Mechanical Engineering from Wichita State University between 1995 and 1997. Their education further included certifications in Project Management, Software Architecture, and Medical Device Development from UC Berkeley Extension, PMI, and UC Irvine Extension, respectively. Wei also obtained certificates in Six Sigma and LEAN black belt practices from ASQ and Agile Product Development SCRUM Master from Agile Product Development in 2009 and 2015, respectively.
This person is not in any offices
Sonendo
Sonendo is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices and offers patients an effective, less invasive, and less painful alternative to traditional root canal therapy.